Sign inJoin waitlistJoin the waitlist

AY

Amulya Yellala

Physician · University of Nebraska Medical Center College of Medicine

Credentials: · · ·

History

University of Nebraska Medical Center College of Medicine
2022–Present

Hematology and Medical Oncology
Allegheny Health Network Medical Education Consortium
2019–2022
Internal Medicine
Allegheny Health Network
2016–2019
Bachelor of Medicine, Bachelor of Surgery
2011–2015

Research

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
Blood · 2022 · 81 citations
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025
Journal of the National Comprehensive Cancer Network · 2025 · 56 citations
Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis
Cancers · 2024 · 52 citations

Jairam Krishnamurthy
3 papers
Anthony Elias
2 papers
Apar Ganti
2 papers
Bethany Anderson
2 papers
Bryan Schneider
2 papers
Bunny Pozehl
2 papers
CS
Cesar Santa-Maria
2 papers
CD
Chau Dang
2 papers
Doreen Agnese
2 papers
Harold Burstein
2 papers
HS
Hatem Soliman
2 papers
Helen Chew
2 papers

Clinical trials

Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy
Principal investigator · Active not recruiting · Phase 2
University of Nebraska
2022–2032
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery
Principal investigator · Completed · Phase 2
University of Nebraska
2015–2025
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer
Principal investigator · Completed · Phase 2
University of Nebraska
2012–2025
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037